Table 2.
Unadjusted models | Adjusted model a | ||||
---|---|---|---|---|---|
OR | [95% CI] | OR | [95% CI] | ||
Th1-type cytokines b | IL-1β | 0.90 | [0.77, 1.05] | 0.76 | [0.59, 0.97] |
IFN-γ | 1.01 | [0.87, 1.18] | 1.09 | [0.91, 1.30] | |
TNF-α | 0.92 | [0.79, 1.08] | 0.93 | [0.77, 1.13] | |
Th2-type cytokines b | IL-1ra | 1.01 | [0.89, 1.14] | 1.06 | [0.90, 1.24] |
IL-4 | 1.00 | [0.86, 1.17] | 1.05 | [0.88, 1.25] | |
IL-6 | 0.99 | [0.86, 1.15] | 1.19 | [0.96, 1.48] | |
Growth factors b | G-CSF | 0.84 | [0.72, 0.99] | 0.78 | [0.64, 0.95] |
TPO | 1.09 | [0.95, 1.25] | 1.16 | [1.00, 1.36] |
Abbreviations: IL, interleukin; RA, receptor antagonist; G-CSF, granulocyte colony stimulating factor; IFN, interferon; TNF, tumor necrosis factor; TPO, thrombopoietin
Adjusted model included terms for all cytokines, maternal age, and gestational age at sample collection
Biomarkers were standardized by dividing assay-determined concentration by the standard deviation among controls